Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-002406

Chief Business & Legal Officer sold 3,155 shares at $15.17 ($47,861)

  • Chief Business & Legal Officer acquired 28,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nickson Philip · Chief Business & Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-02 Grant or award : show line 1 in the form +28,000 64,000 D
2026-01-05 Sale : show line 2 in the form −3,155 $15.17 $47,861 60,845 D
Open-market sales · 3,155 sh · avg $15.17 · $47,861

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-02 Grant or award : show line 3 in the form Stock Option (Right to Buy) +126,000 126,000 D
Loading xslF345X05/ownership.xml…